Evidence map›Paper›PMID 25360758›Full record

ArticlePloS one2014

Community-based evaluation of PMTCT uptake in Nyanza Province, Kenya.

Pamela K Kohler, John Okanda, John Kinuthia, Lisa A Mills, George Olilo, Frank Odhiambo, Kayla F Laserson, Brenda Zierler, Joachim Voss, Grace John-Stewart

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Pamela K KohlerGlobal Health and Psychosocial & Community Health, University of Washington, Seattle, Washington, United States of America.
John OkandaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
John KinuthiaKenyatta National Hospital/University of Nairobi, Nairobi, Kenya.
Lisa A MillsKenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Research and Public Health Collaboration, Kisumu, Kenya; and Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, United States of America.
George OliloCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Frank OdhiamboCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Kayla F LasersonKenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Research and Public Health Collaboration, Kisumu, Kenya; and Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, United States of America.
Brenda ZierlerBiobehavioral Nursing & Health Systems, University of Washington, Seattle, Washington, United States of America.
Joachim VossBiobehavioral Nursing & Health Systems, University of Washington, Seattle, Washington, United States of America.
Grace John-StewartGlobal Health, Medicine, Pediatrics, and Epidemiology, University of Washington, Seattle, Washington, United States of America.
Kenya Medical Research Institute · KENational Center for HIV/AIDS Viral Hepatitis STD and TB Prevention · USNeurobehavioral Systems · USUniversity of Washington · USUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Judith Tsui · 1988 to 2026
$104.9M
A Kenya Free of AIDS: Harnessing interdisciplinary science for HIV preventionR24HD056799 · NICHD · UNIVERSITY OF WASHINGTON · PI MORRIS, WANDA MARTINA · 2007 to 2011
$2.4M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
NIAID NIH HHS P30 AI027757NICHD NIH HHS K24 HD054314NICHD NIH HHS R24 HD056799
6 · The paper itself

Abstract

introductionFacility-based assessments of prevention of mother-to-child HIV transmission (PMTCT) programs may overestimate population coverage. There are few community-based studies that evaluate PMTCT coverage and uptake.

methodsDuring 2011, a cross-sectional community survey among women who gave birth in the prior year was performed using the KEMRI-CDC Health and Demographic Surveillance System in Western Kenya. A random sample (n = 405) and a sample of women known to be HIV-positive through previous home-based testing (n = 247) were enrolled. Rates and correlates of uptake of antenatal care (ANC), HIV-testing, and antiretrovirals (ARVs) were determined.

resultsAmong 405 women in the random sample, 379 (94%) reported accessing ANC, most of whom (87%) were HIV tested. Uptake of HIV testing was associated with employment, higher socioeconomic status, and partner HIV testing. Among 247 known HIV-positive women, 173 (70%) self-disclosed their HIV status. Among 216 self-reported HIV-positive women (including 43 from the random sample), 82% took PMTCT ARVs, with 54% completing the full antenatal, peripartum, and postpartum course. Maternal ARV use was associated with more ANC visits and having an HIV tested partner. ARV use during delivery was lowest (62%) and associated with facility delivery. Eighty percent of HIV infected women reported having their infant HIV tested, 11% of whom reported their child was HIV infected, 76% uninfected, 6% declined to say, 7% did not recall; 79% of infected children were reportedly receiving HIV care and treatment.

conclusionsCommunity-based assessments provide data that complements clinic-based PMTCT evaluations. In this survey, antenatal HIV test uptake was high; most HIV infected women received ARVs, though many women did not self-disclose HIV status to field team. Community-driven strategies that encourage early ANC, partner involvement, and skilled delivery, and provide PMTCT education, may facilitate further reductions in vertical transmission.

Indexed as

Residence CharacteristicsAdolescentAdultAnti-HIV AgentsData CollectionFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalKenyaPatient Acceptance of Health CarePregnancyPregnancy Complications, InfectiousPrenatal DiagnosisYoung AdultAnti-HIV Agents

Identifiers

PMID25360758
PMCPMC4215877
OpenAlexW2049054671

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.